Pacific Biosciences Of California (PACB) Non-Current Assets (2010 - 2026)

Pacific Biosciences Of California has reported Non-Current Assets for 17 years, with the latest figure at $412.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 0.73% year-over-year to $412.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 billion (down 43.89% YoY), and the FY2025 full-year result was $409.0 million, down 46.52% from the prior year.
• Non-Current Assets for Q1 2026 stood at $412.8 million, up from $409.0 million in the prior quarter.
• The five-year high for Non-Current Assets was $1.0 billion in Q3 2023, with the low at $408.9 million in Q3 2025.
• Average Non-Current Assets over 5 years is $767.3 million, with a median of $905.1 million recorded in 2022.
• Year-over-year, Non-Current Assets surged 1499.18% in 2022 and slumped 58.12% in 2025.
• Tracing PACB's Non-Current Assets over 5 years: stood at $915.0 million in 2022, then rose by 9.72% to $1.0 billion in 2023, then dropped by 23.83% to $764.8 million in 2024, then plunged by 46.52% to $409.0 million in 2025, then rose by 0.93% to $412.8 million in 2026.
• The last three Non-Current Assets figures came in at $412.8 million (Q1 2026), $409.0 million (Q4 2025), and $408.9 million (Q3 2025), per Business Quant data.

Peer Comparison